IVVD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
IVVD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Invivyd has the Momentum Rank of 0.
For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.
Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.
For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Thank you for viewing the detailed overview of Invivyd's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Adimab, Llc | 10 percent owner, other: See Remarks | 7 LUCENT DRIVE, LEBANON NH 03766 |
William E. Duke | officer: Chief Financial Officer | C/O VALERITAS, INC., 750 ROUTE 202 SOUTH, SUITE 600, BRIDGEWATER NJ 08807 |
Sara Cotter | director | 1735 MARKET STREET, FLOOR 23, PHILADELPHIA PA 19103 |
Allen Robert D. Iii | officer: Chief Scientific Officer | 1601 TRAPELO ROAD, SUITE 178, WALTHAM MA 02451 |
Stacy Price | officer: Chief Tech. and Manuf. Officer | 1601 TRAPELO ROAD, SUITE 178, WALTHAM MA 02451 |
Jeremy Gowler | officer: COO & CCO | 1601 TRAPELO ROAD, SUITE 178, WALTHAM MA 02451 |
Rebecca Dabora | officer: Chief Tech and Manuf Officer | 303 WYMAN STREET, SUITE 300, WALTHAM MA 02451 |
Peter Schmidt | officer: Chief Medical Officer | 1601 TRAPELO ROAD, SUITE 178, WALTHAM MA 02451 |
Jill Andersen | officer: Chief Legal Officer, Secretary | 303 WYMAN STREET, SUITE 300, WALTHAM MA 02451 |
Christine Lindenboom | director | 1601 TRAPELO ROAD, SUITE 178, WALTHAM MA 02451 |
Frederick W Driscoll | officer: Interim CFO | |
David Hering | director, officer: Chief Executive Officer | 303 WYMAN STREET, SUITE 300, WALTHAM MA 02451 |
Marc Elia | director, other: See Remarks | C/O SQZ BIOTECHNOLOGIES COMPANY, 200 ARSENAL YARDS BOULEVARD, SUITE 210, WATERTOWN MA 02472 |
M28 Capital Management Lp | other: See Remarks | 700 CANAL STREET, 2ND FLOOR, STAMFORD CT 06902 |
Clive Meanwell | director, 10 percent owner | THE MEDICINES CO, 8 SYLVAN WAY, PARSIPPANY NJ 07054 |
From GuruFocus
By Marketwired • 11-02-2023
By sperokesalga sperokesalga • 03-30-2023
By Marketwired • 09-11-2023
By Marketwired • 08-10-2023
By PRNewswire PRNewswire • 03-30-2023
By Business Wire Business Wire • 05-27-2023
By Marketwired • 07-17-2023
By Business Wire • 07-08-2023
By sperokesalga sperokesalga • 04-25-2023
By Marketwired • 09-06-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.